Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Dr Simona Valletta, a postdoctoral research in MRC MHU, who was awarded an Intermediate Research Fellowship from the Kay Kendall Leukaemia Fund.

Profile photograph of Dr Simona Valletta

Dr Valletta’s fellowship will be based in the Nerlov group (Radcliffe Department of Medicine) and will explore the effects of the ageing bone marrow microevironment in the prognosis of acute myeloid leukaemia (AML).

AML is an aggressive form of leukaemia and one of the most common forms of acute leukaemia in adults. Disease relapse and multidrug resistance increase dramatically with age, particularly over the age of 65.

Previous research has examined how ageing affects haematopoietic stem cells, including how it may skew their differentiation to particular lineages or limit their repopulation potential following treatments such as bone marrow transplant. However, it is unclear how the bone marrow microenvironment where these cells reside is itself affected by age. The stem niche has a crucial role in maintaining and regulating normal haematopoiesis.

Dr Valletta’s research will specifically examine how the ageing microenvironment influences Leukaemic Initiating Cells, cells with stem cell-like properties that are able to initiate leukaemia, ultimately leading to AML. The project hopes to understand how the niche influences Leukaemic Initiating Cells’ behavior and how they contribute to increased chemotherapy resistance and disease relapse in elderly patients. Ultimately the researchers hope to identify new drug targets that may be able to counteract these effects and improve treatments for AML patients.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

RDM researchers awarded Oxford-Bristol Myers Squibb Fellowships

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Six new Oxford-BMS Fellowships for 2021 were announced.

New atlas revealed of bone marrow haematopoiesis during development

A new study published this week in Nature, provides the most detailed analysis so far of the prenatal development of blood and immune cells in the bone marrow.

Changes in blood cell production over the human lifetime may hold clues to patterns of disease

A new paper published this week in Cell Reports reveals that changes in the gene expression of blood stem cells occur across the human lifetime; an important step in the understanding and treatment of blood disorders.